Steeb Theresa, Heppt Markus V, Erdmann Michael, Wessely Anja, Klug Stefanie J, Berking Carola
Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Comprehensive Cancer Center Erlangen - European Metropolitan Region of Nuremberg, Erlangen, Germany.
JMIR Res Protoc. 2021 Dec 13;10(12):e31860. doi: 10.2196/31860.
In 2008, a nationwide skin cancer screening (SCS) program was implemented in Germany. However, participation rates remain low.
The overall objective of the HELIOS study is to identify subgroup-specific invitation and communication strategies to increase informed SCS participation in Germany.
Focus group discussions will be performed in Erlangen, Germany, to explore potential invitation and communication strategies as well as possible barriers and motivating factors to participate in SCS. Male and female patients of different age groups who have already been diagnosed with skin cancer, as well as participants without a prior diagnosis of skin cancer, will be invited. Based on these results, an online questionnaire will be developed to identify subgroup-specific invitation strategies. A random sample of 2500 persons from the general population aged >35 years from the Munich area will be contacted to complete the questionnaire. Besides descriptive analysis, multinomial logistic regression will be performed. Additionally, a cluster analysis will be conducted to discover patterns or similarities among the participants.
Recruitment for the focus group studies started in February 2021 and is ongoing. As of August 2021, we have enrolled 39 participants. We expect to end enrollment in the qualitative study in September 2021 and to finish the analysis in December 2021. The second part of the study will then start in January 2022.
The results of this project will enable us to derive improved and more efficient invitation and communication strategies for SCS. These may be implemented in the future to facilitate increased SCS uptake and early skin cancer detection.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/31860.
2008年,德国实施了一项全国性皮肤癌筛查(SCS)计划。然而,参与率仍然很低。
HELIOS研究的总体目标是确定特定亚组的邀请和沟通策略,以提高德国皮肤癌筛查的知情参与率。
将在德国埃尔朗根进行焦点小组讨论,以探索潜在的邀请和沟通策略,以及参与皮肤癌筛查的可能障碍和激励因素。将邀请已被诊断患有皮肤癌的不同年龄组的男性和女性患者,以及之前未被诊断患有皮肤癌的参与者。基于这些结果,将开发一份在线问卷,以确定特定亚组的邀请策略。将联系慕尼黑地区年龄>35岁的普通人群中的2500人随机样本,以完成问卷。除了描述性分析外,还将进行多项逻辑回归分析。此外,将进行聚类分析,以发现参与者之间的模式或相似性。
焦点小组研究的招募工作于2021年2月开始,目前仍在进行中。截至2021年8月,我们已招募了39名参与者。我们预计定性研究将于2021年9月结束招募,并于2021年12月完成分析。该研究的第二部分将于2022年1月开始。
该项目的结果将使我们能够得出改进的、更有效的皮肤癌筛查邀请和沟通策略。这些策略未来可能会被实施,以促进皮肤癌筛查的增加和早期皮肤癌的检测。
国际注册报告识别码(IRRID):DERR1-10.2196/31860